Funding for this research was provided by:
Cancer Research UK
Text and Data Mining valid from 2018-05-31
Received: 9 August 2017
Accepted: 30 April 2018
First Online: 31 May 2018
Change Date: 28 March 2019
Change Type: Correction
Change Details: .
Ethics approval and consent to participate
: Not applicable – this article does not contain any studies with human participants or animals performed by any of the authors.
: AS has received consulting fees or honoraria from Roche, Gilead, Abbvie, Janssen and Novartis. MRM has received consulting fees from pharmaceutical companies with CDF-funded drugs, including Roche, Merck, Novartis, BMS and GSK, and has conducted clinical trials for which his institution is funded by the pharmaceutical industry. SR has received fees from Takeda for leadership training. RWB is a non-executive director of Celgene Corporation. LM and SW declare that they have no conflict of interest.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.